Skip to main content
SpringerLink
Log in

The Combination of Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio Predicts Survival for Non-small Cell Lung Cancer Patients

  • Thoracic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Iwasaki M, Ishihara S, Okada S, et al. Prognostic impact of using combined plasma fibrinogen level and neutrophil-to-lymphocyte ratio in resectable non-small cell lung cancer. Ann Surg Oncol. 2022;29:5699–707. https://doi.org/10.1245/s10434-022-11835-3.

    Article  PubMed  Google Scholar 

  2. Zhang Y, Cao J, Deng Y, et al. Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer. Clin Sao Paulo Braz. 2020;75:e993.

    Article  Google Scholar 

  3. Wang Y, Hu X, Xu W, et al. Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: a retrospective study. Thorac Cancer. 2019;10:1402–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Li Y, Guo H, Li X, et al. Association of COF-NLR with clinicopathological characteristics and prognosis of patients with non-small cell lung cancer after curative resection. Clin Focus. 2016;31:762–6.

    CAS  Google Scholar 

  5. Wang H, Zhao J, Zhang M, et al. The combination of plasma fibrinogen and neutrophil-lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non-small cell lung cancer. J Cell Physiol. 2018;233:4216–24.

    Article  CAS  PubMed  Google Scholar 

  6. Huang W, Wang S, Zhang H, et al. Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer. Cancer Biol Med. 2018;15:88–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Yin L. Prognostic significance of fibrinogen and neutrophil-lymphocyte ratio in advanced non-small cell lung cancer[D]. Qingdao: Qingdao University, 2019.

Download references

Acknowledgments

This study was funded by the Chengdu High-level Key Clinical Specialty Construction Project.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, The Public Health Clinical Center of Chengdu, Chengdu, People’s Republic of China

    Sheng Gong MD & Xiaojun Yao MD

Authors
  1. Sheng Gong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaojun Yao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaojun Yao MD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gong, S., Yao, X. The Combination of Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio Predicts Survival for Non-small Cell Lung Cancer Patients. Ann Surg Oncol 30, 4062–4063 (2023). https://doi.org/10.1245/s10434-023-13379-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13379-6

Search

Navigation